Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Spravato Recent news which mentions Spravato Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression July 23, 2024 Tickers JNJ NEWS Tags Psychedeclis for TDR ketamine depression Ketamine From Benzinga Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch May 18, 2024 Tickers ABBV AMGN CURLF JAZZ Tags Markets TEVA Market News From Benzinga Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions October 17, 2023 Tickers JNJ Tags Markets Cannabis Market News From Benzinga Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year July 20, 2023 Tickers JNJ Tags Benzinga Psychedelics Ketamine From Benzinga Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion July 22, 2022 Tickers DELCF NAD Tags Markets Cannabis Market News From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
